Related Experiment Video
Updated: May 19, 2026
08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
The VitraCell: A new in vitro test setup for intravitreal dosage forms
Felix Reichel1, Tobias Auel1, Björn Fischer1
1Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstraße 1, 40225 Düsseldorf, Germany.
Summary
A new VitraCell model mimics the human vitreous body for testing intravitreal therapies. This in vitro model offers a promising alternative to animal testing for drug development, aligning with the 3Rs principles.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Pharmacology
Background:
- Aging populations face increased ocular diseases, necessitating advanced intravitreal therapies.
- Current preclinical testing relies heavily on animal models, prompting the need for ethical and efficient alternatives.
- The 3Rs principles (replace, reduce, refine) guide the development of superior preclinical testing methods.
Purpose of the Study:
- To introduce VitraCell, an innovative in vitro model of the human vitreous body.
- To evaluate VitraCell's suitability for assessing intravitreal drug delivery and release kinetics.
- To compare VitraCell's performance against traditional compendial methods.
Main Methods:
- VitraCell features a central compartment with a hyaluronic acid and agar-based vitreous substitute.
- Simulated intravitreal injections of various drugs (triamcinolone acetonide, paracetamol) and dosage forms were performed.
- Drug release, diffusion, and elimination were analyzed, alongside stability tests and comparisons with USP Apparatus 4 and 7.
Main Results:
- VitraCell demonstrated distinct release and diffusion profiles for different intravitreal formulations.
- The model showed promising initial correlation with existing in vivo data.
- The vitreous substitute maintained stability over three weeks, and VitraCell provided more physiologically relevant release rates than compendial methods.
Conclusions:
- VitraCell is a suitable in vitro model for evaluating intravitreal therapies, offering biorelevance and potential to reduce animal use.
- The model accurately characterizes drug release and diffusion, supporting preclinical drug development.
- VitraCell represents a significant advancement in in vitro testing for intravitreal dosage forms, aligning with the 3Rs.
Related Concept Videos
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:16Methods for Studying Drug Absorption: In vitro
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...